Dismiss Modal
Elizabeth A. Beierle, MD

Elizabeth A. Beierle, MD

Pediatric General Surgery


Medical Office

1600 7th Avenue South
Lowder Bldg., Suite 300
Birmingham , AL 35233

Medical Office

1600 7th Avenue South
Clinic 14
Birmingham , AL 35233

About Me

Charles D. McCrary Chair in Pediatric Surgery

Professor of Surgery and Pediatrics, Surgical Director, Hepatobiliary Clinic


University of Florida , General Surgery

Medical School:
University of North Dakota

St. Christopher's Hospital for Children, Philadelphia, PA , pediatric surgery

Baylor College of Medicine

University of North Dakota

Board Certifications

American Board of Surgery (1970)

American Board of Surgery - Pediatric Surgery (1970)

Honors and Awards

Women Who Shape the State (2016), Top Doctors in Birmingham (2015-2017)

Special Interests

Dr. Bierle is an Associate Professor of Surgery Patient Care Emphasis: Pediatric surgical oncology, neonatal surgery, burn and trauma care Research: Dr. Beierle's research interest lies in the study of pediatric solid tumors, specifically the signal transduction pathways involved in neuroblastoma.


pediatric surgical oncology

Professional Organizations

FACS, FAAP, APSA, SUS, Southern Surgical, American Surgical


1. Regulates focal adhesion kinase expression in human neuroblastoma. J Biol Chem, 282:125 2. 53. Beierle EA, Ma X, Stewart J, Nyberg C, Trujillo A, Cance WG, Golubovskaya VM. Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma. Cell Cycle, 9: 1005-15, 2010. 3. 66. Gillory LA, Megison ML, Stewart JE, Mroczek-Musulman E, Nabers HC, Waters AM, Kelly V, Coleman JM, Markert JM, Gillespie GY, Friedman GK, Beierle EA. Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma. PLOS ONE, 8:e77753, 1-19, 2013. 4. Waters AM, Stewart JE, Atigadda VR, Mroczek-Musulman E, Muccio DD, Grubbs CJ, Beierle EA. Pre-clinical evaluation of a novel RXR agonist for the treatment of neuroblastoma. Molec Cancer Ther, 14:1559-1569, 2015. 5. Waters AM, Stafman LL, Garner EF, Mruthyunjayappa S, Stewart JE, Mroczek-Musulman E, Beierle EA. Targeting focal adhesion kinase suppresses the malignant phenotype in rhabdomyosarcoma cells. Trans Oncol, 9:263-272, 2016.